| Detection of immunogenic cell death and its relevance for cancer therapy J Fucikova, O Kepp, L Kasikova, G Petroni, T Yamazaki, P Liu, L Zhao, ... Cell death & disease 11 (11), 1013, 2020 | 540 | 2020 |
| Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage A Fluckiger, R Daillère, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ... Science 369 (6506), 936-942, 2020 | 246 | 2020 |
| Crizotinib-induced immunogenic cell death in non-small cell lung cancer P Liu, L Zhao, J Pol, S Levesque, A Petrazzuolo, C Pfirschke, C Engblom, ... Nature communications 10 (1), 1486, 2019 | 234 | 2019 |
| eIF2α phosphorylation is pathognomonic for immunogenic cell death L Bezu, A Sauvat, J Humeau, LC Gomes-da-Silva, K Iribarren, S Forveille, ... Cell Death & Differentiation 25 (8), 1375-1393, 2018 | 203 | 2018 |
| Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade G Ferrere, MT Alou, P Liu, AG Goubet, M Fidelle, O Kepp, S Durand, ... JCI insight 6 (2), 2021 | 172 | 2021 |
| The oncolytic peptide LTX-315 triggers immunogenic cell death H Zhou, S Forveille, A Sauvat, T Yamazaki, L Senovilla, Y Ma, P Liu, ... Cell death & disease 7 (3), e2134-e2134, 2016 | 112 | 2016 |
| Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus LC Gomes‐da‐Silva, L Zhao, L Bezu, H Zhou, A Sauvat, P Liu, S Durand, ... The EMBO journal 37 (13), e98354, 2018 | 107 | 2018 |
| Extracellular nucleosides and nucleotides as immunomodulators O Kepp, F Loos, P Liu, G Kroemer Immunological reviews 280 (1), 83-92, 2017 | 107 | 2017 |
| Immunosuppression by mutated calreticulin released from malignant cells P Liu, L Zhao, F Loos, C Marty, W Xie, I Martins, S Lachkar, BO Qu, ... Molecular cell 77 (4), 748-760. e9, 2020 | 97 | 2020 |
| Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy Y Wang, W Xie, J Humeau, G Chen, P Liu, J Pol, Z Zhang, O Kepp, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 53 | 2020 |
| 3, 4‐Dimethoxychalcone induces autophagy through activation of the transcription factors TFE 3 and TFEB G Chen, W Xie, J Nah, A Sauvat, P Liu, F Pietrocola, V Sica, ... EMBO molecular medicine 11 (11), e10469, 2019 | 52 | 2019 |
| The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization H Zhou, S Forveille, A Sauvat, V Sica, V Izzo, S Durand, K Müller, P Liu, ... Oncotarget 6 (29), 26599, 2015 | 49 | 2015 |
| IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms Q Wu, AL Tian, B Li, M Leduc, S Forveille, P Hamley, W Galloway, W Xie, ... Journal for immunotherapy of cancer 9 (6), 2021 | 47 | 2021 |
| Identification of pharmacological agents that induce HMGB1 release P Liu, L Zhao, F Loos, K Iribarren, S Lachkar, H Zhou, LC Gomes-da-Silva, ... Scientific reports 7 (1), 14915, 2017 | 45 | 2017 |
| The oncolytic peptide LTX-315 triggers necrotic cell death S Forveille, H Zhou, A Sauvat, L Bezu, K Müller, P Liu, L Zitvogel, ... Cell Cycle 14 (21), 3506-3512, 2015 | 44 | 2015 |
| A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency J Le Naour, P Liu, L Zhao, S Adjemian, Z Sztupinszki, J Taieb, C Mulot, ... Cancer Discovery 11 (2), 408-423, 2021 | 36 | 2021 |
| Crizotinib–a tyrosine kinase inhibitor that stimulates immunogenic cell death P Liu, L Zhao, O Kepp, G Kroemer Oncoimmunology 8 (7), e1596652, 2019 | 35 | 2019 |
| PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer P Liu, J Chen, L Zhao, A Hollebecque, O Kepp, L Zitvogel, G Kroemer Oncoimmunology 11 (1), 2093518, 2022 | 33 | 2022 |
| Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects A Petrazzuolo, M Perez-Lanzon, I Martins, P Liu, O Kepp, V Minard-Colin, ... Cell Death & Disease 12 (8), 713, 2021 | 33 | 2021 |
| The oncolytic compound LTX-401 targets the Golgi apparatus H Zhou, A Sauvat, LC Gomes-da-Silva, S Durand, S Forveille, K Iribarren, ... Cell Death & Differentiation 23 (12), 2031-2041, 2016 | 28 | 2016 |
Guido KroemerUniversité de Paris Cité, Hôpital Européen George Pompidou - AP-HP, Gustave Roussy Cancer CampusEmail confirmado em inserm.fr
